TP53 and diabetes mellitus: For instance, high-glucose culture conditions lead to the down-regulation of cardiomyocyte IGF-1R via p53, similarly to doxorubicin [36], in agreement with the increased risk of anthracycline cardiotoxicity faced by oncological patients who also suffer from diabetes [25].